{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:47:27Z","timestamp":1768866447170,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1007\/bf03343660","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T04:56:45Z","timestamp":1394513805000},"page":"860-865","source":"Crossref","is-referenced-by-count":53,"title":["Complete remission of Nelson\u2019s syndrome after 1-year treatment with cabergoline"],"prefix":"10.1007","volume":"22","author":[{"given":"R.","family":"Pivonello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Di Salle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Filippella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Colao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"BF03343660_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM195807242590403","volume":"259","author":"DH Nelson","year":"1958","unstructured":"Nelson D.H., Meakin J.W., Dealy J.B., Matson D.D., Emerson K., Thorn G.W. ACTH producing tumor of the pituitary gland. N. Engl. J. Med. 1958, 259: 161\u2013164.","journal-title":"N. Engl. J. Med."},{"key":"BF03343660_CR2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archinte.1978.03630280045017","volume":"138","author":"KL Cohen","year":"1978","unstructured":"Cohen K.L., Noth R.H., Pechinski T. Incidence of pituitary tumors following adrenalectomy: a long-term follow-up study of patients treated for Cushing\u2019s disease. Arch. Intern. Med. 1978, 138: 575\u2013579.","journal-title":"Arch. Intern. Med."},{"key":"BF03343660_CR3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/edrv-3-3-229","volume":"3","author":"DC Aron","year":"1982","unstructured":"Aron D.C., Findling J.W., Fitzgerald P.A., Forsham P.H., Wilson C.B., Tyrrel J.B. Cushing\u2019s syndrome: problems in management. Endocr. Rev. 1982, 3: 229\u2013244.","journal-title":"Endocr. Rev."},{"key":"BF03343660_CR4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2265.1983.tb00046.x","volume":"19","author":"AA Kasperlik-Zaluska","year":"1983","unstructured":"Kasperlik-Zaluska A.A., Nielubowics J., Wislawski J., Hartwig W., Zaluska J., Jeske W., Migdalska B. Nelson\u2019s syndrome: incidence and prognosis. Clin. Endocrinol. 1983, 19: 693\u2013698.","journal-title":"Clin. Endocrinol."},{"key":"BF03343660_CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/edrv-14-4-443","volume":"14","author":"JW Miller","year":"1993","unstructured":"Miller J.W., Crapo L. The medical treatment of Cushing\u2019s syndrome. Endocr. Rev. 1993, 14: 443\u2013458.","journal-title":"Endocr. Rev."},{"key":"BF03343660_CR6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(81)92349-7","volume":"1","author":"TJ Jones","year":"1981","unstructured":"Jones T.J., Gilman B., Beckford U. Effect of treatment with sodium valproate and diazepam on plasma corticotropin in Nelson\u2019s syndrome. Lancet 1981, 1: 1179\u20131181.","journal-title":"Lancet"},{"key":"BF03343660_CR7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/jcem-56-5-985","volume":"56","author":"A Dornhorst","year":"1983","unstructured":"Dornhorst A., Jenkins J.S., Lamberts S.W.J., Abraham R.R., Wynn V., Beckford U., Gillham B., Jones M.T. The evaluation of sodium valproate in the treatment of Nelson\u2019s syndrome. J. Clin. Endocrinol. Metab. 1983, 56: 985\u2013991.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343660_CR8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/acta.0.1190435","volume":"119","author":"P Loli","year":"1988","unstructured":"Loli P., Berselli M.E., Vignati F., De Grandi C., Tagliaferri M. Size reduction of an ACTH-secreting pituitary macroadenoma in Nelson\u2019s syndrome by sodium valporate: effect of withdrawal and re-institution of treatment. Acta Endocrinol. 1988, 119: 435\u2013442.","journal-title":"Acta Endocrinol."},{"key":"BF03343660_CR9","first-page":"514","volume":"82","author":"LB Mercado-Asis","year":"1997","unstructured":"Mercado-Asis L.B., Yanovski J.A., Tracer H.L., Chik C.L., Cutler G.B. Acute effect of bromocriptine, cyproheptadine and valproic acid on plasma adrenocorticotropin secretion in Nelson\u2019s syndrome. J. Clin. Endocrinol. Metab. 1997, 82: 514\u2013517.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343660_CR10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jcem-36-2-277","volume":"36","author":"DT Krieger","year":"1973","unstructured":"Krieger D.T. Lack of responsiveness to L-Dopa in Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 1973, 36: 277\u2013284.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343660_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2265.1990.tb00855.x","volume":"32","author":"HM Whitehead","year":"1990","unstructured":"Whitehead H.M., Beacom R., Sheridan B., Atkinson A.B. The effect of cyproheptadine and\/or bromocriptine on plasma ACTH levels in patients cured of Cushing\u2019s disease by bilateral adrenalectomy. Clin. Endocrinol. 1990, 32: 193\u2013201.","journal-title":"Clin. Endocrinol."},{"key":"BF03343660_CR12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(76)90656-5","volume":"2","author":"SWJ Lamberts","year":"1976","unstructured":"Lamberts S.W.J., Birkenhager J.C. Bromocriptine in Nelson\u2019s syndrome and Cushing\u2019s disease. Lancet 1976, 2: 811.","journal-title":"Lancet"},{"key":"BF03343660_CR13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1210\/jcem-51-2-307","volume":"51","author":"SWJ Lamberts","year":"1980","unstructured":"Lamberts S.W.J., Klijn J.G.M., De Quijada M., Timmermans H.A.T., Uitterlinden P., De Jong F.H., Birkenhager J.C. The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing\u2019s disease and Nelson\u2019s syndrome. J. Clin. Endocrinol. Metab. 1980, 51: 307\u2013311.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343660_CR14","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","volume":"331","author":"J Webster","year":"1990","unstructured":"Webster J., Piscitelli G., Polli A., Ferrari C., Ismail I., ScanIon M.F., for the Cabergoline Comparative Study Group. A comparison of cabergoline and bromocriptine on plasma ACTH levels in patients cured of Cushing\u2019s disease by bilateral adrenalectomy. N. Engl. J. Med. 1990, 331: 904\u2013909.","journal-title":"N. Engl. J. Med."},{"key":"BF03343660_CR15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jcem-63-4-941","volume":"63","author":"C Ferrari","year":"1986","unstructured":"Ferrari C., Barbieri C., Caldara R. Long-Iasting prolactin lowering effect of cabergoline, a new dopamine-agonist, in hyperprolactinemic patients. J. Clin. Endocrinol. Metab. 1986, 63: 941\u2013945.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343660_CR16","first-page":"753","volume":"24","author":"V Pascal-Vigneron","year":"1995","unstructured":"Pascal-Vigneron V., Weryha G., Bose M., Leclerc J. Hyperprolactinemic amenorrhea: treatment with cabergoline versus bromocriptine. Presse Med. 1995, 24: 753\u2013759.","journal-title":"Presse Med."},{"key":"BF03343660_CR17","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem.82.3.3822","volume":"82","author":"A Colao","year":"1997","unstructured":"Colao A., Di Sarno A., Sarnacchiaro F., Ferone D., Di Renzo G., Merola B., Annunziato L., Lombardi G. Prolactinomas resistant to standard dopamine-agonists respond to chronic cabergoline treatment. J. Clin. Endocrinol. Metab. 1997, 82: 876\u2013883.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343660_CR18","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jcem.82.11.4368","volume":"82","author":"A Colao","year":"1997","unstructured":"Colao A., Di Sarno A., Landi M.L., Cirillo S., Sarnacchiaro F., Facciolli G., Pivonello R., Cataldi M., Merola B., Annunziato L., Lombardi G. Long term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J. Clin. Endocrinol. Metab. 1997, 82: 3574\u20133579.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343660_CR19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199109263251301","volume":"325","author":"EH Oldfield","year":"1991","unstructured":"Oldfield E.H., Doppman J.L., Nieman L.K., Chrousos G.P., Miller D.L., Kats D.A., Cutler G.B., Loriaux D.L. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing\u2019s syndrome. N. Engl. J. Med. 1991, 325: 897\u2013905.","journal-title":"N. Engl. J. Med."},{"key":"BF03343660_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.0690001","volume":"69","author":"MT Jones","year":"1976","unstructured":"Jones M.T., Hillhouse E.W., Burden J. Effect of various putative neurotrasmitters on the secretion of corticotrophin-releasing hormone from the rat hypothalamus in vitro: a model of neurotrasmitters involved. J. Endocrinol. 1976, 69: 1\u201310.","journal-title":"J. Endocrinol."},{"key":"BF03343660_CR21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1210\/jcem-54-2-286","volume":"54","author":"SWJ Lamberts","year":"1982","unstructured":"Lamberts S.W.J., De Lange S.A., Stefanko S.Z. Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or intermediate lobe in Cushing\u2019s disease: differences in the regulation of hormone secretion. J. Clin. Endocrinol. Metab. 1982, 54: 286\u2013291.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343660_CR22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2265.1986.tb01668.x","volume":"24","author":"M McNicol","year":"1986","unstructured":"McNicol M., Teasdale G.M., Beastall G.H. A study of corticotroph adenomas in Cushing\u2019s disease: no evidence of intermediate lobe origin. Clin. Endocrinol. 1986, 24: 715\u2013722.","journal-title":"Clin. Endocrinol."},{"key":"BF03343660_CR23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0014-2999(90)90367-F","volume":"187","author":"M Strolin-Benedetti","year":"1976","unstructured":"Strolin-Benedetti M., Dostert P., Barone D., Efthymiopoulos C., Peretti G., Roncucci R. In vivo interactions of cabergoline with rat brain dopamine receptors labelled with (3H)N-n-propyInorapomorphine. Eur. J. Pharmacol. 1976, 187: 399\u2013408.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03343660_CR24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jcem-60-2-328","volume":"60","author":"AB Atkinsons","year":"1985","unstructured":"Atkinsons A.B., Chestnutt A., Crothers E., Woods R., Weaver J.A., Kennedy L., Sheridan B. Cyclical Cushing\u2019s disease: two distinct rhythms in a patient with a basophil adenoma. J. Clin. Endocrinol. Metab. 1985, 60: 328\u2013332.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343660.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03343660\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T05:31:05Z","timestamp":1565242265000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03343660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["BF03343660"],"URL":"https:\/\/doi.org\/10.1007\/bf03343660","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}